NeuroSense Therapeutics Ltd. ( NRSNW) - Stock Earnings
NRSNW Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -2.4 million USD | — USD |
| 2025Q3 | -3.2 million USD | — USD |
| 2025Q4 | -3.2 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
NRSNW Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -10.1 million USD | — USD |
| 2024 | -10.2 million USD | — USD |
| 2025 | -11.1 million USD | — USD |
| 2026 Est. | — | — |
NRSNW
Price: $0.01
52 week price:
Earnings Per Share: -0.94 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 3227
Market Capitalization: 986667